Literature DB >> 15967064

Clinical management of eosinophilic gastrointestinal disorders.

Shabnam Foroughi1, Calman Prussin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15967064     DOI： 10.1007/s11882-005-0062-4

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.806


× No keyword cloud information.
  8 in total

1.  Elemental diet improves steroid-dependent eosinophilic gastroenteritis and reverses growth failure.

Authors:  C Justinich; A Katz; C Gurbindo; G Lepage; Z Chad; L Bouthillier; E Seidman
Journal:  J Pediatr Gastroenterol Nutr       Date:  1996-07       Impact factor: 2.839

2.  Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density.

Authors:  D L Schneider; E L Barrett-Connor
Journal:  Arch Intern Med       Date:  1997-06-09

3.  Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate.

Authors:  Jonathan E Teitelbaum; Victor L Fox; Frank J Twarog; Samuel Nurko; Don Antonioli; Gerald Gleich; Kamran Badizadegan; Glenn T Furuta
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

4.  Intravenous zoledronic acid in postmenopausal women with low bone mineral density.

Authors:  Ian R Reid; Jacques P Brown; Peter Burckhardt; Zebulun Horowitz; Peter Richardson; Ulrich Trechsel; Albert Widmer; Jean-Pierre Devogelaer; Jean-Marc Kaufman; Philippe Jaeger; Jean-Jacques Body; Maria Luisa Brandi; Johann Broell; Raffaele Di Micco; Andrea Riccardo Genazzani; Dieter Felsenberg; Joachim Happ; Michael J Hooper; Jochen Ittner; Georg Leb; Hans Mallmin; Timothy Murray; Sergio Ortolani; Alessandro Rubinacci; Maria Saaf; Goran Samsioe; Leon Verbruggen; Pierre J Meunier
Journal:  N Engl J Med       Date:  2002-02-28       Impact factor: 91.245

5.  Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents.

Authors:  Jonathan E Markowitz; Jonathan M Spergel; Eduardo Ruchelli; Chris A Liacouras
Journal:  Am J Gastroenterol       Date:  2003-04       Impact factor: 10.864

6.  Eosinophilic gastroenteritis.

Authors:  M Lee; W G Hodges; T L Huggins; E L Lee
Journal:  South Med J       Date:  1996-02       Impact factor: 0.954

Review 7.  Eosinophilic gastrointestinal disorders (EGID).

Authors:  Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

8.  Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

Authors:  Jennifer K Garrett; Sean C Jameson; Blythe Thomson; Margaret H Collins; Lynne E Wagoner; Debbie K Freese; Lisa A Beck; Joshua A Boyce; Alexandra H Filipovich; Joyce M Villanueva; Steven A Sutton; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-12-12       Impact factor: 10.793
  8 in total
  6 in total

Review 1.  Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract.

Authors:  Dagmar Simon; Andrew Wardlaw; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-04-14       Impact factor: 10.793

Review 2.  Eosinophilic Gastroenteritis and Colitis: a Comprehensive Review.

Authors:  Vikas Uppal; Portia Kreiger; Erika Kutsch
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

3.  Eosinophilic enteritis: a rare cause of diarrhoea.

Authors:  Ana Lladó; João Oliveira; Pedro Silva; Sofia Pinheiro
Journal:  BMJ Case Rep       Date:  2013-09-30

Review 4.  Gastrointestinal eosinophilia.

Authors:  Li Zuo; Marc E Rothenberg
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 5.  Eosinophilic disorders in various diseases.

Authors:  Jocelyn Celestin; Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.919

6.  A case report about eosinophilic enteritis presenting as abdominal pain.

Authors:  Hairong Zhang; Cuimei Ma; Yuan Xue; Zongjing Hu; Zhen Xu; Yibo Wang; Guangxi Zhou
Journal:  Medicine (Baltimore)       Date:  2021-10-01       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.